These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32212330)

  • 1. Prevalence of ABCC3-1767G/A polymorphism among patients with antiretroviral-associated hepatotoxicity.
    Singh H; Lata S; Choudhari R; Dhole TN
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1124. PubMed ID: 32212330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity.
    Singh H; Lata S; Dhole TN; Gangakhedkar RR
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00598. PubMed ID: 30864294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.
    Singh H; Nambiar N; Samani D; Gangakhedkar RR
    Curr Mol Med; 2019; 19(3):206-215. PubMed ID: 30973108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
    Singh H; Lata S; Nema V; Samani D; Ghate M; Gangakhedkar RR
    APMIS; 2017 Jun; 125(6):523-535. PubMed ID: 28370504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patients.
    Singh H; Lata S; Gangakhedkar RR
    APMIS; 2018 Nov; 126(11):842-851. PubMed ID: 30357957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
    Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
    Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 polymorphisms and susceptibility to ARV associated hepatotoxicity.
    Singh H; Samani D; Nain S; Dhole TN
    Microb Pathog; 2019 Aug; 133():103544. PubMed ID: 31121270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.
    Singh H; Dhotre K; Shyamveer ; Choudhari R; Verma A; Mahajan SD; Ali N
    Mol Genet Genomic Med; 2024 Mar; 12(3):e2362. PubMed ID: 38451012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity.
    Singh H; Samani D; Jadhav S
    Microb Pathog; 2021 Dec; 161(Pt A):105243. PubMed ID: 34656700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
    Giacomelli A; Riva A; Falvella FS; Oreni ML; Cattaneo D; Cheli S; Renisi G; Di Cristo V; Lupo A; Clementi E; Rusconi S; Galli M; Ridolfo AL
    BMC Infect Dis; 2018 Nov; 18(1):556. PubMed ID: 30419834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1RN and IL-1
    Singh H; Samani D; Nema V; Ghate MV; Gangakhedkar RR
    Mediators Inflamm; 2018; 2018():4398150. PubMed ID: 29849489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.
    Ciccacci C; Borgiani P; Ceffa S; Sirianni E; Marazzi MC; Altan AM; Paturzo G; Bramanti P; Novelli G; Palombi L
    Pharmacogenomics; 2010 Jan; 11(1):23-31. PubMed ID: 20017669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.
    Sasaki T; Hirota T; Ryokai Y; Kobayashi D; Kimura M; Irie S; Higuchi S; Ieiri I
    Drug Metab Pharmacokinet; 2011; 26(4):374-86. PubMed ID: 21512263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity.
    Singh HO; Jadhav S; Samani D; Dhole TN
    Curr Genomics; 2019 Feb; 20(2):134-150. PubMed ID: 31555064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention.
    Zou JJ; Fan HW; Chen SL; Tan J; He BS; Xie HG
    Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):504-9. PubMed ID: 23692149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.
    Petros Z; Lee MT; Takahashi A; Zhang Y; Yimer G; Habtewold A; Schuppe-Koistinen I; Mushiroda T; Makonnen E; Kubo M; Aklillu E
    OMICS; 2017 Apr; 21(4):207-216. PubMed ID: 28388302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3.
    Kobayashi K; Ito K; Takada T; Sugiyama Y; Suzuki H
    Pharmacogenet Genomics; 2008 Sep; 18(9):823-33. PubMed ID: 18698235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.